Headquarter in Switzerland with a US subsidiary, InSphero is a pioneer in 3D cell based technology engineered for highly predictive drug discovery and safety testing. The company, headquartered in Zurich, Switzerland, currently collaborates with more than ten global pharmaceutical and cosmetics companies to implement the company’s patent-pending microtissue technology in the customer’s development
work-flow. InSphero is a spin-off company of the Swiss Federal Institute of Technology (ETH) Zurich and the University Zurich and was founded in 2009 by Dr. Jan Lichtenberg, Dr. Jens Kelm, Dr. Wolfgang Moritz and Prof. InSphero has its production, laboratory and office space at the Technopark in Zurich, Switzerland. InSphero was recognized for its scientific and commercial achievements with a number of awards, including the VentureKick award, Heuberger Entrepreneurial Award and CTIstartup certification. InSphero’s founders combine more than 15 years of experience in microtissue engineering and over 10 years in microfluidics and laboratory automation with the goal to deliver highly functional, reliable and easy-to-use microtissues. InSphero AG
Technoparkstrasse 1
CH-8005 Zurich
Switzerland
Tel.: +41-44-515049-0
Fax +41-44-515049-1
